Article Correctness Is Author's Responsibility: De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumors

Newswise imageA decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumor attack.